Company / Revenue
Neogen Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$822.4M
FY2025
5-year range
$414.2M / $924.2M
FY2021-FY2025
Trend
-8.1%
vs FY2024
Sector context
#109 of 156
Health Care
What the data says
At $822M, Neogen's revenue ranks #109 of 156 in the Health Care sector. Declined from $924M to $822M over the past 2 years.
Based on SEC 10-K filings.
$822M in FY2025 with a 5-year CAGR of +15.6%.
Declined from $924M to $822M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +25.3%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Sector benchmark
#109 of 156 in Health CareTop 70% of 156This company $822.4M Sector average $19.0B
▼
-95.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.6%, indicating consistent growth.
- In FY2025, revenue decreased 8.1% year-over-year.
- Ranks #109 out of 156 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $822.4M | -8.1% |
| FY2024 | $894.7M | -3.2% |
| FY2023 | $924.2M | +121.0% |
| FY2022 | $418.2M | +1.0% |
| FY2021 | $414.2M | +4.1% |
| FY2020 | $397.9M | +11.1% |
| FY2019 | $358.3M | +11.5% |
| FY2018 | $321.3M | +13.5% |
| FY2017 | $283.1M | +14.4% |
| FY2016 | $247.4M | +19.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026